Alcon Inc.
ALC • Medical - Specialties
$70.50
▼ -1.58 (-2.19%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$35.05B
Growth
4.7%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 5.6%Positive free cash flow · 3.49Consistent free cash flow · 5/5Manageable debt level · 0.24Healthy liquidity · 2.12
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 5, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:35 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$70.50
Change-2.19%
Shares Out490.20M
Market Cap$35.05B
Enterprise Value$38.23B
52W Range61.84 - 90.41
Beta0.70
P/E42.99
P/S3.31
P/B1.58
P/FCF21.48
EV/Sales3.61
Price$70.50
Change-2.19%
Shares Out490.20M
Market Cap$35.05B
Enterprise Value$38.23B
52W Range61.84 - 90.41
Beta0.70
P/E42.99
P/S3.31
P/B1.58
P/FCF21.48
EV/Sales3.61
EV/EBITDA17.99
EV/FCF23.42
Earnings Yield2.33%
FCF Yield4.66%
Dividend Yield0.48%
Gross Margin55.24%
Oper. Margin13.08%
Profit Margin9.42%
Debt/Eq0.24
Current Ratio2.12
Quick Ratio1.33
Revenue 5Y4.65%
FCF 5Y7.45%
Target$73.43
Target Upside4.16%
Target Median$79.00
Target Range35.00 - 85.00
Volume3.69M
Avg Volume2.06M
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
76
out of 100
Business Quality
Margins, moat, returns
69/100
Financial Strength
Debt, cash, stability
74/100
Growth Potential
Revenue and expansion
84/100
Price Attractiveness
Cheap or expensive today
61/100
Why this score▼
Positive revenue growth · 5.6%Positive free cash flow · 3.49Consistent free cash flow · 5/5Manageable debt level · 0.24Healthy liquidity · 2.12Expensive earnings multiple · 39.8
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 26 analyst votes · 2026-09-03
73/100
Bullish
Bullish
14
Hold
10
Bearish
2
Price Target
2026-08-12
Low
$70.00
Mean
$82.83
Median
$83.50
High
$97.00
🧾
No insider activity
No recent insider transactions available.